Publication Name	World Journal of Hepatology
Manuscript ID	14044
Country	Greece

Received	2014-09-16 08:48
Peer-Review Started	2014-09-20 16:42
To Make the First Decision	2014-11-14 19:50
Return for Revision	2014-11-19 16:12
Revised	2014-12-10 00:00
Second Decision	2014-12-15 13:38
Accepted by Journal Editor-in-Chief	2014-12-16 15:08
Accepted by Executive Editor-in-Chief	2014-12-31 13:24
Articles in Press	2014-12-31 13:24
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-03-20 12:13
Publish the Manuscript Online	2015-03-31 15:58

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Hepatitis C in hemodialysis patients
Manuscript Source	Invited Manuscript
All Author List	Smaragdi Marinaki, John N Boletis, Stratigoula Sakellariou and Ioanna K Delladetsima
Funding Agency and Grant Number
Corresponding Author	Ioanna K Delladetsima, Associate Professor, First Department of Pathology, Medical School, University of Athens, 75 Mikras Asias Str, Goudi, 11527 Athens, Greece. jokadelladetsima@hotmail.com
Key Words	Hemodialysis; Hepatitis C infection; Interferon; Ribavirin; Protease inhibitors
Core Tip	Despite reduction of hepatitis C prevalence, hemodialysis (HD) patients still comprise a high risk group. HD individuals with chronic hepatitis C virus infection have lower aminotransferase and viral levels, milder histological features and a lower frequency of cirrhosis and hepatocellular carcinoma. However, liver disease is related to higher cardiovascular and all-cause mortality in this patient population. According to current recommendations, choice of treatment is interferon or pegylated interferon, whilst low doses of ribavirin also seem to have promising results. Data regarding new protease inhibitors are still lacking.
Publish Date	2015-03-31 15:58
Citation	Marinaki S, Boletis JN, Sakellariou S, Delladetsima IK. Hepatitis C in hemodialysis patients. World J Hepatol 2015; 7(3): 548-558
URL	http://www.wjgnet.com/1948-5182/full/v7/i3/548.htm
DOI	http://dx.doi.org/10.4254/wjh.v7.i3.548

Full Article (PDF)	WJH-7-548.pdf
Full Article (Word)	WJH-7-548.doc
Manuscript File	14044-Review.doc
Answering Reviewers	14044-Answering reviewers.pdf
Conflict-of-Interest Disclosure Form	14044-Conflict-of-interest statement.pdf
Copyright License Agreement	14044-Copyright assignment.pdf
Peer-review Report	14044-Peer review(s).pdf
Scientific Misconduct Check	14044-CrossCheck.jpg
Scientific Editor Work List	14044-Scientific editor work list.pdf